4-Butylresorcinol Powder: Complete Cosmetic Formulation Guide
4-Butylresorcinol Powder is a concentrated cosmetic tone-care active used by formulators developing products for a brighter-looking, more even-looking complexion and the appearance of dark spots or post-blemish marks. This complete guide explains what 4-Butylresorcinol is, how it differs from other resorcinol derivatives, how to dissolve the powder, which solvent systems to screen, how much to use and how to build a stable serum, cream or emulsion.
Important: 4-Butylresorcinol is a concentrated cosmetic raw ingredient, not a finished skincare product. It must be accurately weighed, fully pre-dissolved and incorporated into a properly developed cosmetic formulation. Do not apply the powder directly to skin, use it neat, ingest it or add it to a purchased finished product.
Shop JustGlow 4-Butylresorcinol Powder for current pack sizes, availability, batch information and technical documents.
In this 4-Butylresorcinol formulation guide: identity and chemistry; how it works in a cosmetic concept; safe claim wording; recommended use levels; solubility and solvent selection; DMI and other solvent systems; serum and emulsion processing; example formulation frameworks; pH, stability and packaging; troubleshooting; FAQs; storage, SDS handling and UK compliance.
4-Butylresorcinol Powder at a glance
| Property | JustGlow information and formulation guidance |
|---|---|
| INCI name | 4-Butylresorcinol |
| Other names | 4-n-Butylresorcinol; Rucinol is a well-known name used for a specific branded material, so do not imply that every generic powder is that branded grade |
| Ingredient category | Cosmetic tone-care and brightening active |
| CAS number | 18979-61-8 |
| Molecular formula | C10H14O2 |
| Molecular weight | 166.22 g/mol |
| Current batch | LYPH260420 |
| Batch purity | 99.4% by HPLC, according to the current JustGlow COA |
| Batch appearance | White powder |
| Batch melting point | Approximately 53°C, according to the current COA |
| Solubility | Poor water solubility; requires a validated solvent or solubilisation system |
| JustGlow development guidance | 0.1–0.3% can be a meaningful starting range for an uneven-tone formulation; confirm the final level against the current technical documents and safety assessment |
| Suitable formats | Serums, emulsions, creams, lotions, gels and other properly developed leave-on cosmetic systems |
| Processing | Pre-dissolve before incorporation; use controlled heat only as needed and test the complete formula for precipitation and colour change |
Batch-document note: the analytical figures above refer to the current JustGlow batch record. Always use the COA and SDS supplied for the batch you are actually using. Do not substitute data from a different 4-Butylresorcinol grade or from a branded product with a different carrier system.
What is 4-Butylresorcinol?
4-Butylresorcinol, also called 4-n-butylresorcinol, is a substituted resorcinol derivative used in cosmetic tone-care formulations. Its chemical structure contains a butyl group and two phenolic hydroxyl groups on a benzene ring. The molecule is more oil-compatible than very polar water-soluble powders, but it is still not freely soluble in water and may require a carefully selected solvent system.
4-Butylresorcinol is sometimes discussed alongside the branded ingredient Rucinol. The names should not be treated as automatically interchangeable: a branded material may have its own purity, specification, solvent guidance, safety data and supporting studies. For JustGlow's generic cosmetic powder, use the INCI name 4-Butylresorcinol and the batch-specific technical documents.
What does 4-Butylresorcinol do in cosmetic formulation?
- Supports tone-care product development: it is used in formulas designed to improve the appearance of uneven-looking tone and dullness.
- Targets appearance-focused concepts: it can be included in serums and creams designed around the appearance of dark spots or post-blemish marks.
- Works at a low percentage: 0.1–0.3% can materially change the direction of an uneven-tone formulation, so accurate weighing is important.
- Fits multi-active systems: it may be combined with compatible cosmetic ingredients such as alpha-arbutin, tranexamic acid, 3-O-ethyl ascorbic acid or other tone-care materials, subject to full-formula compatibility.
- Requires a controlled solvent phase: the quality of the pre-dissolution step often determines whether the finished product remains uniform.
These statements describe a cosmetic formulation role and do not guarantee a result in every finished product. Do not present 4-Butylresorcinol as a medicine or as a treatment for melasma, hyperpigmentation, acne, post-inflammatory pigmentation, eczema or any other medical condition.
How does 4-Butylresorcinol work in a tone-care concept?
Research on 4-n-butylresorcinol has examined its interaction with enzymes involved in melanin formation, including tyrosinase and tyrosinase-related protein-1. This provides a scientific rationale for researching it in cosmetic tone-care formulations.
Research findings are not the same as a guaranteed consumer claim. A laboratory assay, a published study using a specific 0.3% serum or a study using a branded material does not prove that every product containing generic 4-Butylresorcinol will produce the same result. The finished product, concentration, vehicle, packaging, use instructions and evidence must all be considered.
Cosmetic claim wording: what can you say?
| Safer cosmetic positioning | Wording to avoid without a specific legal and scientific basis |
|---|---|
| Helps create a brighter-looking complexion | Treats melasma or hyperpigmentation |
| Supports a more even-looking skin tone | Cures pigmentation or prevents disease |
| Helps improve the appearance of dark spots or post-blemish marks | Erases dark spots permanently |
| For professionally developed tone-care formulations | Medical whitening treatment |
| Formulated with 4-Butylresorcinol, a researched cosmetic tone-care ingredient | Guaranteed tyrosinase inhibition in every finished product |
Do not use “skin whitening” or medical treatment language as a substitute for evidence and legal review. JustGlow's safer positioning is professional cosmetic formulation for a brighter-looking, more even-looking complexion and the appearance of uneven tone.
Recommended 4-Butylresorcinol use level
For development work, 0.1–0.3% is a sensible starting range. The current product information intentionally does not state a universal legal maximum because the correct concentration depends on the grade, finished product, intended market, exposure, claims, safety assessment and technical documentation.
| 4-Butylresorcinol level | Development context |
|---|---|
| 0.05–0.10% | Low-level screening for a multi-active formula or a product where the formulator wants to minimise total active load. |
| 0.10–0.20% | Practical starting range for many cosmetic tone-care prototypes. |
| 0.20–0.30% | Stronger development range consistent with published 0.3% serum research; requires careful solvent, stability and tolerance assessment. |
| Above 0.30% | Do not increase automatically. Obtain appropriate technical and safety support for the exact grade and intended market before proceeding. |
The percentage is calculated against the total finished formula. In a 100 g batch, 0.1% equals 0.10 g, 0.2% equals 0.20 g and 0.3% equals 0.30 g. Use a calibrated balance suitable for small quantities.
How to calculate 4-Butylresorcinol in a finished formula
| Target level | 100 g batch | 200 g batch | 300 g batch |
|---|---|---|---|
| 0.10% | 0.10 g | 0.20 g | 0.30 g |
| 0.20% | 0.20 g | 0.40 g | 0.60 g |
| 0.30% | 0.30 g | 0.60 g | 0.90 g |
If you make a stock solution, count the solvent and active together in the 100% formula. For example, a 10% stock contains 10% 4-Butylresorcinol and 90% solvent. Adding 3 g of that stock to a 100 g finished formula delivers 0.30 g active, equal to 0.30%.
Is 4-Butylresorcinol water-soluble?
No. 4-Butylresorcinol has poor water solubility and should not be sprinkled directly into water, hydrosol, a water gel or a finished cream. Direct addition can leave visible particles, uneven active distribution and later precipitation.
Prepare a separate solvent premix first. The best solvent depends on the final format, target concentration, pH, water content, other actives and the intended packaging.
Which solvents can be screened?
| Solvent or carrier | How to use it in development | What to test |
|---|---|---|
| Dimethyl Isosorbide (DMI) | Useful candidate for a controlled active premix in serums, emulsions and selected anhydrous systems. | Clarity after dilution, sensory feel, pH, precipitation and packaging compatibility. |
| Propanediol or Pentylene Glycol | May be screened as a water-compatible co-solvent or part of a mixed solvent system. | Actual solubility at the target concentration, tackiness, viscosity and precipitation during cooling. |
| Propylene Glycol | May be useful in selected water-containing systems where the complete formula tolerates it. | Clarity, skin feel, preservative compatibility and the final solvent balance. |
| Ethanol | Can dissolve some aromatic powders, but evaporation and flammability must be controlled. | Solvent loss, packaging, odour, skin feel, flammability controls and crystallisation after evaporation. |
| Polar cosmetic esters | May be useful in selected anhydrous or oil-phase systems. | True dissolution, haze, separation, odour and low-temperature stability. |
These are screening options, not universal solubility guarantees. A solvent that dissolves 4-Butylresorcinol in a small clear vial may not maintain it after water, emulsifier, electrolytes, acids, other actives or oils are added.
Dimethyl Isosorbide (DMI) is one candidate solvent to evaluate. Read the DMI formulation guide for solvent-premix and stability considerations.
How to dissolve 4-Butylresorcinol correctly
- Review the batch documentation. Confirm the INCI, batch, purity, appearance, storage and safety information.
- Choose the target percentage. Start with 0.1–0.3% and calculate the exact mass for the batch size.
- Select a solvent system. Choose one solvent or a compatible blend based on the intended water/oil format.
- Make a small trial first. Test the active at the final intended concentration rather than relying on a highly dilute stock solution.
- Pre-wet the powder. Add the powder gradually to the solvent while stirring. Avoid dry pockets on the bottom or sides of the vessel.
- Use controlled heat if necessary. Because the current COA lists a melting point of approximately 53°C, a controlled 50–60°C development trial may assist wetting and dissolution. Do not assume that melting alone proves long-term solubility.
- Protect the premix. Minimise unnecessary exposure to light, air, moisture and prolonged heat.
- Confirm a true solution. Inspect the premix after cooling. Check for particles, haze, sediment and crystals.
- Add to the correct phase. Introduce the uniform premix into the water phase, oil phase or cool-down phase selected for the formula.
- Measure the finished product. Check appearance, odour, pH, viscosity and any colour change after equilibration.
- Run stability testing. A clear concentrate is not evidence that the finished formula will remain stable after dilution or storage.
Using 4-Butylresorcinol in a water-based serum
A water-based serum requires a validated solvent system because 4-Butylresorcinol is poorly water-soluble. The active should first be dissolved in DMI, a glycol blend or another validated solvent system before gradual incorporation into the water phase.
- Reserve the required amount of water or solvent phase.
- Prepare the 4-Butylresorcinol premix separately and confirm that it is uniform.
- Add the premix slowly with mixing. Avoid pouring it into a polymer-thickened gel in one concentrated addition.
- Check whether the solvent changes viscosity or creates local precipitation.
- Adjust the pH only after all critical ingredients are incorporated.
- Add preservative according to the selected system and verify microbiological protection.
- Inspect after 24–48 hours and during stability storage.
Water-based tone-care serum framework
| Ingredient group | Development starting point | Function or consideration |
|---|---|---|
| Purified water | Quantity sufficient to 100% | Continuous aqueous phase |
| 4-Butylresorcinol | 0.10–0.30% | Tone-care active; pre-dissolve before adding to water |
| DMI | 3–10% as required by the solvent trial | Solvent/carrier; test clarity and sensory feel |
| Propanediol or Pentylene Glycol | Use a level appropriate to the selected solvent system | Co-solvent and humectant; avoid excessive tackiness |
| Optional compatible tone-care active | Use the supplier's guidance | Check pH, solubility, preservation and total active burden |
| Thickener | Use the selected polymer's recommended level | Check viscosity after the solvent premix is added |
| Preservative | Use the supplier-recommended level and validated system | 4-Butylresorcinol is not a preservative |
| pH adjuster | Quantity sufficient for the selected system | Confirm active, preservative and polymer compatibility |
This is a development framework, not a finished commercial formula. A water-based serum requires preservation, microbiological testing, packaging assessment, stability testing and professional safety assessment.
Using 4-Butylresorcinol in an emulsion cream or lotion
For an oil-in-water emulsion, 4-Butylresorcinol may be incorporated through a water-compatible solvent premix or a suitable oil/solvent side phase. The correct addition point depends on the solvent, emulsifier, polymer and other actives.
- Pre-dissolve the active before adding it to the main batch.
- Do not add the dry powder directly to a cold finished cream.
- Test addition before emulsification and during cool-down if the solvent is heat-sensitive.
- Check whether the solvent changes emulsion viscosity or separation behaviour.
- Measure pH after equilibration and recheck it during stability.
- Use suitable opaque or light-protective packaging if the complete active system is light-sensitive.
Using 4-Butylresorcinol in an anhydrous serum
An anhydrous serum can be an elegant format, but a low-water system does not automatically solve the solubility problem. DMI or another polar solvent may need to be combined with a compatible oil-phase carrier, and the complete system must be checked for separation.
Start with a small active-solvent concentrate. Add the remaining emollients slowly while mixing and observe the product after cooling. Pay particular attention to cloudiness, sediment and crystals after the solvent is diluted with low-polarity oils.
Anhydrous tone-care serum framework
| Ingredient group | Development starting point | Important check |
|---|---|---|
| 4-Butylresorcinol | 0.10–0.30% | True dissolution after dilution and cooling |
| DMI or another validated polar solvent | 5–10% as required by the solubility trial | Separation, feel, packaging and final clarity |
| Oil-soluble emollients | Quantity sufficient to 100% | Compatibility with the solvent and active |
| THDC or another compatible oil-soluble active | Use the selected ingredient's guidance | Total active load, oxidation, colour and stability |
| Tocopherol | Use a suitable oil-phase support level | Do not treat it as a preservative |
Do not assume that an anhydrous formula is automatically stable or safe. Check the complete system for oxidation, precipitation, packaging interaction and consumer tolerance.
4-Butylresorcinol with other tone-care ingredients
4-Butylresorcinol can be considered alongside other cosmetic tone-care ingredients, but combining several actives increases the formulation and safety-assessment burden.
- Alpha Arbutin: review pH, water-phase solubility, heat exposure and total brightening-active positioning.
- Tranexamic Acid: review the water phase, pH, preservation and the effect of salts or electrolytes on the active system.
- 3-O-Ethyl Ascorbic Acid: confirm the solvent system, pH and stability of the vitamin C derivative.
- THDC: oil-soluble THDC may fit an oil or emulsion system, but the 4-Butylresorcinol solvent must remain compatible with the oil phase.
- Sepiwhite MSH: assess its own solubility and processing requirements rather than assuming both actives use the same phase.
- Acetyl Zingerone: check solvent capacity, colour, pH and antioxidant-system compatibility.
Do not combine every available brightening ingredient simply because the individual materials are popular. A simpler, stable and well-preserved formula is often easier to assess than a crowded active system.
4-Butylresorcinol and pH
The finished pH should be selected for the complete formula, including the solvent system, preservative, polymer, emulsifier and all other actives. A mildly acidic to near-neutral range is often practical for leave-on tone-care products, but the current raw material does not provide one universal finished-product pH.
Measure the pH after the formula has equilibrated. Check for pH drift during stability testing and observe whether a pH adjustment changes clarity, colour or precipitation.
Heat, melting point and processing
The current JustGlow COA lists a melting point of approximately 53°C. A controlled 50–60°C trial may therefore help the formulator wet and dissolve the powder, but melting the powder is not the same as proving that it will remain dissolved after cooling or dilution.
- Use the lowest practical temperature that creates a uniform premix.
- Do not hold the active at elevated temperature longer than necessary.
- Protect the powder and premix from prolonged light and air exposure.
- Do not add the active to a hot formula without considering the stability of the other ingredients.
- Check the premix after cooling and again after it has been diluted into the finished product.
Stability testing for 4-Butylresorcinol formulas
| Test | What to observe |
|---|---|
| Immediately after manufacture | Colour, odour, clarity, visible particles, pH, viscosity and fill appearance |
| After 24–48 hours | Delayed haze, sediment, crystals, colour shift, separation and viscosity change |
| Low-temperature storage | Precipitation, crystallisation and changes that reverse on warming |
| Room-temperature storage | Appearance, odour, pH, viscosity and active-system stability |
| Approximately 40°C storage | Oxidation, colour change, solvent loss, separation and packaging interaction |
| Light exposure | Colour and odour changes where the packaging or use conditions permit light exposure |
| Freeze–thaw cycling | Irreversible precipitation or emulsion failure where relevant to distribution |
| Packaging compatibility | Interaction with bottle, pump, gasket, liner, coating and adhesive |
For water-containing products, also assess microbiological quality and preservative efficacy. 4-Butylresorcinol is not a preservative and cannot replace a broad-spectrum preservation system.
Common 4-Butylresorcinol formulation problems
The powder will not dissolve
Check the active percentage, solvent choice, temperature and mixing time. Make a smaller, more concentrated solvent trial and add the powder gradually. Do not assume that water, glycerin or an ordinary oil will dissolve it.
The concentrate is clear but the finished product becomes cloudy
The solvent capacity may have fallen after dilution into water or oil. The active may have exceeded its solubility in the final vehicle. Test the active at the final concentration in the final base before scaling up.
Crystals appear after cooling
Warmth may have temporarily held the active in solution. Reduce the active level, increase or change the compatible solvent, adjust the solvent-to-base ratio or choose a different product format. Check at low temperature and after several weeks.
The formula changes colour
Investigate light, oxygen, heat, trace metals, pH, raw-material age, contamination and packaging. Compare with a retained control and record the change. Do not correct an unexplained colour change by adding more ingredients.
The serum feels sticky
Review the total level of DMI, glycols, glycerin and other humectants. A lower solvent level or different co-solvent may improve sensory feel, provided the active remains dissolved.
The emulsion becomes thin or separates
The solvent system may be affecting the polymer, emulsifier or phase balance. Compare different addition points and make a control batch without 4-Butylresorcinol. Test the solvent alone as well as the complete active premix.
The product causes irritation
Review the whole formula, not only 4-Butylresorcinol. Check concentration, pH, solvent level, preservative, fragrance, exfoliating acids, other actives, contamination and intended use. A raw material must not be used directly on skin.
Handling and safety of the raw powder
The current JustGlow SDS identifies the raw powder as harmful if swallowed and irritating to skin and eyes. This is a handling warning for the concentrated raw material and reinforces why it must not be supplied or used as an undiluted consumer skincare product.
- Use a suitable laboratory balance and clean, dry equipment.
- Avoid inhaling the powder and minimise dust generation.
- Wear the protective equipment specified in the current SDS.
- Avoid contact with eyes and skin during weighing and processing.
- Do not eat, drink or smoke while handling the raw material.
- Keep the container tightly closed and protect it from contamination.
- Read the current SDS before handling and follow its first-aid and spill instructions.
What 4-Butylresorcinol is not
- It is not a finished brightening serum.
- It is not a medicine or medical treatment.
- It is not a preservative.
- It is not a substitute for sunscreen or sun protection.
- It is not automatically stable simply because it dissolves in a hot premix.
- It is not safe to apply neat or to mix into skincare in your hand.
- It does not guarantee the treatment or cure of melasma, hyperpigmentation, acne marks or any disease.
Frequently asked questions about 4-Butylresorcinol Powder
What is 4-Butylresorcinol used for?
4-Butylresorcinol is used as a cosmetic tone-care active in professionally developed serums, creams, lotions and emulsions designed for a brighter-looking, more even-looking complexion and the appearance of dark spots or post-blemish marks.
Is 4-Butylresorcinol the same as Rucinol?
4-Butylresorcinol is also known as 4-n-butylresorcinol, and Rucinol is a well-known branded name associated with this type of ingredient. Do not assume that a generic powder is the same branded grade. Use the actual INCI, batch documentation and supplier specification.
What is the recommended use level?
For development, start around 0.1–0.3% of the finished formula. Confirm the final concentration against the current technical documentation, destination-market requirements and safety assessment.
Is 4-Butylresorcinol water-soluble?
No. It has poor water solubility and should be pre-dissolved in a validated solvent system before being added to a water-containing formula.
Can I dissolve 4-Butylresorcinol in DMI?
DMI is a useful solvent candidate to screen, but the exact concentration and final clarity must be tested. A clear DMI premix may precipitate after it is diluted with water, oils, salts or other actives.
Can I use propylene glycol or Pentylene Glycol?
They may be screened as part of a solvent system, but do not assume that either glycol will dissolve every concentration. Test the actual active-to-solvent ratio and inspect the final formula after cooling and storage.
Can I add the powder directly to a cream?
No. Pre-dissolve it in a compatible solvent system and add the uniform premix at the appropriate stage. Direct powder addition can create particles, uneven dosing and later precipitation.
Can I use 4-Butylresorcinol with Alpha Arbutin or Tranexamic Acid?
They can be considered in a multi-active tone-care concept, but each ingredient may require a different phase, solvent and pH. Check total active load, stability, preservation, packaging and finished-product tolerance.
Can I use it with THDC vitamin C?
It may be possible in an emulsion or carefully designed oil/solvent system. THDC is oil-soluble, while 4-Butylresorcinol needs its own validated solvent phase. Test the interaction and final clarity rather than assuming that both ingredients can simply be mixed together.
Does 4-Butylresorcinol need heat?
Controlled heat may assist dissolution. The current COA lists a melting point of approximately 53°C, so a 50–60°C development trial may be useful. Do not use more heat or longer holding time than necessary.
What pH should a 4-Butylresorcinol serum have?
Choose a pH that is compatible with the active, solvent, preservative, polymer and other ingredients. A mildly acidic to near-neutral range may be practical, but the finished formula must be tested rather than relying on a universal value.
Is 4-Butylresorcinol a preservative?
No. A water-containing 4-Butylresorcinol serum or cream still requires a suitable broad-spectrum preservation system and microbiological assessment.
Can I apply 4-Butylresorcinol powder directly to dark spots?
No. The powder is a concentrated raw ingredient for formulation use only. Do not apply it neat or mix it into skincare in your hand.
Can I claim that it treats melasma?
Do not use medical treatment claims for an ordinary cosmetic product. Safer cosmetic language describes a brighter-looking, more even-looking complexion and improvement in the appearance of uneven tone, provided the finished-product claims are substantiated.
Storage and technical documents
Keep 4-Butylresorcinol Powder tightly closed, cool and dry, protected from light, moisture, heat and air. Follow the current batch label and technical documents for storage and shelf life. Allow the container to reach room temperature before opening if condensation could form.
View the 4-Butylresorcinol product page, SDS and batch COA.
Professional formulation and UK compliance note
JustGlow 4-Butylresorcinol Powder is supplied as a cosmetic raw ingredient for professional formulation use only. The formulator or finished-product manufacturer is responsible for determining the appropriate concentration, confirming raw-material identity, testing the solvent system, validating preservation, assessing packaging compatibility, substantiating cosmetic claims and meeting the requirements of the intended market.
For a finished cosmetic placed on the Great Britain market, the responsible business must maintain the required product information, obtain an appropriate Cosmetic Product Safety Report, follow good manufacturing practice, ensure compliant labelling and complete the required notification before placing the product on the market. This guide is formulation education and does not replace professional regulatory or safety assessment.
Research and further reading
- Khemis A et al. Evaluation of efficacy and safety of rucinol serum in women with melasma. A vehicle-controlled study of a 0.3% rucinol serum; the study used a specific finished product and does not prove the performance of every raw material or formula.
- Huh SY et al. The efficacy and safety of 4-n-butylresorcinol 0.1% cream for melasma. Published clinical research on a defined 0.1% cream; not a universal use-level or claim permission for every cosmetic.
- Lee SJ et al. 4-n-butylresorcinol enhances proteolytic degradation of tyrosinase. Mechanistic research relevant to the ingredient's scientific background.
Buy 4-Butylresorcinol Powder from JustGlow
View 4-Butylresorcinol Powder – Professional Cosmetic Ingredient for current pack sizes, availability, SDS and batch-specific COA.
Cosmetic ingredient for formulation use only. Do not apply undiluted.